High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.0M
$3,045,489
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $423,760 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-02-02 | $227,618 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Discretionary Sell
|
2026-01-16 | $27,701 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Other
|
2026-01-16 | $21,552 | M | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Klee Justin B.
• CEO
Discretionary Sell
2026-01-15
$1,849,869Large
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Discretionary Sell
|
2026-01-15 | $1,849,869Large | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Other
|
2026-01-15 | $1,492,448Large | M | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-01-06 | $85,589 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2025-09-30 | $3,002 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2025-09-30 | $427,950 | S | Form 4 |